(Q46172948)

English

A population-based study evaluating the impact of sunitinib on overall survival in the treatment of patients with metastatic renal cell cancer

scientific article published in February 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19127560

A population-based study evaluating the impact of sunitinib on overall survival in the treatment of patients with metastatic renal cell cancer (English)

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19127560

0 references

author name string

Daniel Y C Heng

1

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19127560

Kim N Chi

2

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19127560

Nevin Murray

3

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19127560

Tao Jin

4

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19127560

Jorge A Garcia

5

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19127560

Ronald M Bukowski

6

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19127560

Brian I Rini

7

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19127560

Christian Kollmannsberger

8

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19127560

language of work or name

0 references

publication date

1 February 2009

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19127560

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19127560

115

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19127560

776-783

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19127560

4

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19127560

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24051

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24051

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24051

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Français d'Immunothérapie

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24051

7 January 2021

based on heuristic

inferred from DOI database lookup

Medroxyprogesterone, interferon alfa-2a, interleukin 2, or combination of both cytokines in patients with metastatic renal carcinoma of intermediate prognosis: results of a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24051

7 January 2021

based on heuristic

inferred from DOI database lookup

Renal-Cell Carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24051

7 January 2021

based on heuristic

inferred from DOI database lookup

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24051

7 January 2021

based on heuristic

inferred from DOI database lookup

Sorafenib in advanced clear-cell renal-cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24051

7 January 2021

based on heuristic

inferred from DOI database lookup

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24051

7 January 2021

based on heuristic

inferred from DOI database lookup

Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24051

7 January 2021

based on heuristic

inferred from DOI database lookup

Primer: challenges in randomized and observational studies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24051

7 January 2021

based on heuristic

inferred from DOI database lookup

Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24051

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical factors associated with outcome in patients with metastatic clear-cell renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24051

7 January 2021

based on heuristic

inferred from DOI database lookup

Sunitinib efficacy against advanced renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24051

7 January 2021

based on heuristic

inferred from DOI database lookup

Validation and extension of the Memorial Sloan-Kettering prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24051

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunotherapy for advanced renal cell cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD001425.PUB2

Identifiers

10.1002/CNCR.24051

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19127560

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19127560

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46172948&oldid=2097410291"